MK-3281
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MK-3281, covering 2016-05-04 to 2016-05-04. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-3281 in Healthy and Hepatitis C Infected Male Participants (MK-3281-002) [Phase 1]